Evidence-based clinical intelligence, CDSCO guidelines, pricing updates, and patient discussions from active Reddit communities.
Wegovy® (semaglutide 2.4mg, Novo Nordisk) is a selective glucagon-like peptide-1 (GLP-1) receptor agonist sharing 94% structural homology with native human GLP-1. Engineered with a C-18 fatty acid chain spacer and Aib8 substitution, semaglutide exhibits extended half-life characteristics (approximately 165 hours), enabling steady weekly subcutaneous dosing.
The landmark STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program established robust efficacy across diverse international cohorts. In STEP-1, participants receiving 2.4mg weekly lost an average of 14.9% baseline body weight over 68 weeks, with 86% achieving ≥5% loss and 50% achieving ≥15% loss. Furthermore, the SELECT cardiovascular outcomes trial confirmed a 20% reduction in major adverse cardiovascular events (MACE) among patients with established cardiovascular disease.
In Indian clinical practice, Wegovy is administered via the pre-filled FlexTouch pen, stepping through 0.25mg (month 1), 0.5mg (month 2), 1.0mg (month 3), 1.7mg (month 4), and 2.4mg (maintenance), monitored closely by prescribing endocrinologists.
Wegovy is Novo Nordisk's brand of semaglutide approved specifically for chronic weight management, taken as a once-weekly injection. It launched in India in July 2025, and after price cuts its entry doses start around ₹5,660 per month.
In r/WegovyWeightLoss and r/Semaglutide, discussions regarding Wegovy in India center on its dedicated 2.4mg obesity indication, predictable dose-escalation schedule, and substantial 15% average weight reduction. Patients share detailed advice on managing the 0.25mg to 2.4mg monthly step-ups and maintaining long-term weight maintenance.
Community Anecdote (u/DesiWegovyJourney (r/WegovyWeightLoss)) "Escalated from 0.25mg up to 1.7mg over 4 months. Lost 16 kg total. The most remarkable part is how easy it became to decline dessert and large dinner buffets without willpower battles."
Community Anecdote (u/KolkataFitness (r/Semaglutide)) "Make sure you stay hydrated with coconut water or electrolyte powder. On Wegovy you forget to drink water because thirst cues change along with hunger."
Community Anecdote (u/BangalorePhysician (r/medicine)) "STEP-1 trial data holds true in our Indian cohort: ~15% weight loss at 1 year, with dramatic drops in systolic blood pressure and triglyceride levels."
The effect builds gradually as the dose is escalated over weeks. Most people notice reduced hunger and smaller portions within the first month.
They are not suitable for everyone: people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, or who are pregnant should avoid them. Your doctor will screen for these.
Long-term use requires ongoing doctor monitoring — periodic blood work, dose reviews, and a plan for nutrition and muscle preservation. It is not a drug to take casually or without follow-up.
Prices vary by dose, format (vial vs KwikPen), and pharmacy — and they change frequently, so verify the current MRP. Factor in consultation and lab-test costs on top of the drug itself.
If you do drink, keep it occasional and moderate, avoid it around dose-increase weeks when nausea peaks, and discuss your habits openly with your doctor.
BMI = weight in kg ÷ (height in metres)². For reference, at 1.65 m tall, a BMI of 27 is about 73.5 kg and a BMI of 30 is about 81.7 kg.